Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)
Clinical trial NCT02358044 · COMPLETED
Trial details
- NCT number
- NCT02358044
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-27
- Primary completion
- 2015-11-26
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.